Media Newsroom of
Woodland Pharmaceuticals
Woodland Pharmaceuticals is a business dedicated to improving oncology drug discovery and development outcomes. Our initial service offerings are in vivo xenograft models for oncology indications and we are partnered with key alliance companies to extend the capabilities from early drug discovery to "preclinical" modeling with patient-derived tumors.
Woodland Pharmaceuticals Awarded STTR Grant from NCI to Create Liver (HCC) Tumor Bank in Collaboration with Massachusetts General Hospital (MGH)
Woodland Biosciences, a preclinical contract research lab (CRO) in greater Boston announces today the award of an STTR grant from NIH/NCI together with co-applicant Massachusetts General Hospital (MGH). The award, titled "Development, Characterization & Commercialization of a Viably Frozen, Patient-Inclusive…